Passive voice-biomarker intelligence for maritime crew wellness and operational readiness.
Every maritime safety system measures Operational metrics.
VESL measures the one variable no protocol can see: the human signal.
Sources: ITF Seafarers’ Trust, IMO Maritime Safety Reports, Yale Global Health Review, ILO Maritime Labour Convention Data
The maritime industry employs 2 million seafarers and shoreside workers globally. Among these workers, mental health conditions far exceed the general population. Suicides now exceed fatal maritime accidents. Every mechanism for early detection depends on voluntary self-disclosure, and disclosure carries devastating consequences: contract termination, medical disqualification, loss of livelihood.
The result: Employee Assistance Program (EAP) utilization remains 3 to 8 percent, despite 25 percent of seafarers meeting clinical intervention criteria. The system catches people who have already fallen. It has no mechanism to catch people who are currently struggling.
VESL Ambient uses clinically validated voice biomarkers to passively detect indicators of fatigue, stress, depression, anxiety, and cognitive impairment across fleet operations. No wearables. No questionnaires. No self-disclosure required.
requires only 40 seconds from any conversational interaction.
analyzes thousands of acoustic markers in approximately 3 seconds.
operates in English, Spanish, Portuguese, Filipino, Thai, and more.
Clinically validated technology that extracts aggregate biomarker signals from natural voice patterns across maritime operations. No wearables. No questionnaires. No individual tracking.
Detects symptoms and states of depression, anxiety, stress, and mood present in acoustic and linguistic features. Real-time assessment of mood states enables proactive intervention before observable symptoms appear.
Vocal biomarkers signal the presence of cognitive impairment, fatigue accumulation, and neurological changes. The technology models acoustic features specific to each condition to proactively screen for deterioration.
Cost-effective, non-invasive screening for mild cognitive impairment and general clinical transitions. Detecting issues earlier across fleet populations, validated against PHQ-8 and GAD-7 clinical standards.
VESL is powered by Canary Speech's voice biomarker platform, which analyzes millions of acoustic data elements from 40 seconds of natural speech. The platform detects patterns related to fatigue, stress, depression, anxiety, and cognitive impairment using acoustic properties — not spoken content.
VESL analyzes rhythm, cadence, micro-tremors, pitch variation, and thousands of other acoustic markers from natural speech. No transcription. No content analysis. Pure signal from the human voice.
Powered by Canary Speech technology validated across healthcare and research environments. 23 issued patents, 16 pending. IRB-approved. Validated against PHQ-8 and GAD-7 clinical standards. Deployed by leading telehealth platforms.
Aggregate wellness signals across crew populations enable fleet operators to identify systemic risk patterns — fatigue trends, stress accumulation, cognitive load — without individual surveillance or tracking.
Focused on acoustic patterns from consented interactions. Never transcribes or stores spoken content. No individually identifiable data derived from audio. Aggregate reporting only. No automated decisioning.
From offshore energy crews to cruise lines, the demand for human-factor intelligence spans every corner of the $511B maritime economy.
VESL exists because the maritime industry moves 12.3 billion tons of global trade on human decision-making, yet has zero standardized infrastructure for understanding crew wellness. Our technology passively extracts aggregate biomarker signals from 40 seconds of natural speech, detecting fatigue, stress, depression, and cognitive state across fleet operations.
The seagull is historically revered as the reincarnated souls of sailors lost at sea. Mariners believe they act as guardians and guides to those who never returned. Our logo carries that tradition: VESL exists to protect the people who move the world's cargo across oceans.
Clinically validated voice-biomarker platform with 23 issued patents and 16 more pending worldwide. IRB-approved. Validated against PHQ-8 and GAD-7 clinical standards. Deployed in healthcare settings today. Operational in English, Spanish, Portuguese, Filipino, Thai, and more.
VESL is building its founding team. We are currently searching for a Chief Revenue Officer with deep maritime industry experience, established relationships with shipowners, classification societies, and communications vendors. Contact us if you are interested.
VESL will launch VESL Ambient 1.0 shortly. Currently, VESL is engaging with BETA partners in maritime medical and clinical companies and maritime global communications companies. If you are interested in engaging in a BETA test program, we should talk.